Grace Therapeutics, Inc. (GRCE)

NASDAQ: GRCE · Real-Time Price · USD

3.280

+0.075 (2.34%)

At close: Aug 13, 2025, 4:00 PM

3.130

-0.150 (-4.57%)

Pre-market: Aug 14, 2025, 8:00 AM EDT

Grace Therapeutics Market Cap

Grace Therapeutics has a market cap or net worth of $45.36 million as of August 14, 2025. Its market cap has increased by 74.84% in one year.

Market Cap

45.36M

Enterprise Value

25.35M

1-Year Change

74.84%

Ranking

#4607

Market Cap Chart

Since October 24, 2011, Grace Therapeutics's market cap has decreased from $87.20M to $45.36M, a decrease of -47.99%. That is a compound annual growth rate of -4.62%.

Market Cap History

Date	Market Cap	% Change
Aug 12, 2025	44.32M	16.87%
Dec 31, 2024	37.92M	39.61%
Dec 29, 2023	27.16M	21.53%
Dec 30, 2022	22.35M	-59.95%
Dec 31, 2021	55.80M	77.21%
Dec 31, 2020	31.49M	-84.94%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	570.26B
Johnson & Johnson	418.62B
AbbVie	350.91B
AstraZeneca	229.47B
UnitedHealth Group	228.94B
Novartis AG	228.69B
Abbott Laboratories	228.63B
Novo Nordisk	222.88B

Market Cap Rankings